Antimetabolites are chemotherapy drugs used to treat cancer cells from replicating. Chemotherapy is a common cancer treatment that sends drugs through your bloodstream to kill cancer cells and prevent tumor growth. They trick cancer cells into using the drug instead of the molecules it needs to make the genetic material to replicate or DNA. There are different classes of chemotherapy drugs — including antimetabolites, alkylating agents, and topoisomerase inhibitors, among others. Various classes of chemotherapy drugs have different mechanisms of action. This means that each class works differently in the body to destroy cancer cells. Antimetabolites are generally used to treat leukemias and cancers of the breast, ovary, and intestinal tract. However, since the drugs work to restrict the growth of any fast-dividing cell type, they also can be used to treat various other cancers.
Different antimetabolite drugs are taken in different ways based on the drug and the type of cancer being treated. Some antimetabolites are available as tablets or liquids that are taken by mouth every day. Others are given by injection through an intravenous (IV) line that a health care professional inserts into a vein. Often, it’s a specific kind of IV line called a mediport that sits in a large, central vein. Each drug includes specific instructions about how it should be administered.
FutureWise Market Research has published a report that provides an insightful analysis antimetabolite drug market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, antimetabolite drug market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.